Neuroscientific Biopharmaceuticals Ltd (NSB) — Cash Flow Reinvestment Rate

Latest as of June 2024: 0.00x

Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting AU$1.82K (capex AU$1.82K ) from operating cash flow of AU$1.62 Million. See Neuroscientific Biopharmaceuticals Ltd (NSB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$1.82K

Capex + Investments

Operating Cash Flow

AU$1.62 Million

AUD

Capital Expenditures

AU$1.82K

AUD

Neuroscientific Biopharmaceuticals Ltd Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Neuroscientific Biopharmaceuticals Ltd.

Annual Cash Flow Reinvestment Rate for Neuroscientific Biopharmaceuticals Ltd (2024–2024)

Year-by-year capital reinvestment analysis for Neuroscientific Biopharmaceuticals Ltd. See NSB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2024	0.08x	AU$3.63K	AU$44.25K	AU$1.81K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow